Best Practices, Strategies & Use of Novel Biological Responses for Robust Cell-Based Potency Assays

News
Article

Sponsored Content

Cell-based assays (CBAs) are key tools for evaluating the potency of new biologic drugs. Catalent’s transcription-based bioassay simplifies and empowers the testing of new biologics.

Related Content